New study: aspirin use reduces risk of death in hospitalized patients

(University of Maryland School of Medicine) Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news